MedPath

Feasibility Study: Lifting and Tightening Neck Skin in Patients

Not Applicable
Completed
Conditions
Skin Laxity
Interventions
Device: Ulthera System Treatment
Registration Number
NCT01708928
Lead Sponsor
Ulthera, Inc
Brief Summary

Up to 30 subjects will be enrolled. All subjects will receive one Ultherapy treatment to the lower two thirds of the face and neck. Subjects will be equally grouped into those with a history of submentoplasty and or rhytidectomy and those naive to submentoplasty and or rhytidectomy. Follow-up visits will occur at 14, 30, 60, 90 and 180 days following treatment. Study images will be obtained pre-treatment, 30-60 minutes post-treatment, and at each follow-up visit.

Detailed Description

This is a prospective single center study. Subjects will be enrolled one per group as they present. Efficacy will be determined by the change in submental volume and cervicomental angle. GAIS and patient satisfaction questionnaires will also be obtained.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Male or female, aged 30 to 65 years
  • Subject in good health
  • Body Mass index of less than 30
  • Present with unwanted skin laxity in the submental area as demonstrated by a grade 2 or 3 on the Knize scale for classification of cosmetic deformity of the cervicomental angle
  • Previous history of surgical submentoplasty and or rhytidectomy greater than 12 months previous to enrollment and not to exceed 120 months prior to enrollment
  • Understands and accepts the obligation not to receive any other procedures in the submental areas thru the 6 month follow up visit
  • Willingness and ability to comply with protocol requirements including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study
  • Subjects of childbearing potential must have a negative urine pregnancy test result at Visit 1 and be willing able to use an acceptable method of birth control
Exclusion Criteria
  • Pregnant, lactating or planning to become pregnant and or not using a reliable form of birth control
  • Has an active systemic or local skin disease that may alter wound healing
  • Subjects with a prior cosmetic or medical history of submentoplasty and or Rhytidectomy within the last 12 months or greater than 120 months
  • Subjects with a prior cosmetic or medical history of submentoplasty and or Rhytidectomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group AUlthera System TreatmentSubjects who have previous history of submentoplasty and or rhytidectomy
Group BUlthera System TreatmentSubjects naïve to submentoplasty and or rhytidectomy
Primary Outcome Measures
NameTimeMethod
Change in submental volume90 days post-treatment

Measured by the Canfield Vectra® imaging system comparing pre-treatment baseline photos to post-treatment photos.

Secondary Outcome Measures
NameTimeMethod
Overall improvement of the submental area90 days post-treatment

Global Aesthetic Improvement Scale (GAIS) and patient satisfaction questionnaires will be obtained.

Trial Locations

Locations (1)

DeNova Research

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath